1. 4CPS-113 Experience with braf and mek inhibitors in the treatment of metastasic melanoma in a third-level university hospital. (2nd March 2018) Authors: Escoda, A Comes; Castells, G; Carcelero, E; Riu, G Journal: European journal of hospital pharmacy Issue: Volume 25(2018)Supplement 1 Page Start: A94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 4CPS-185 Administration of oral anticancer drugs for patients with swallowing difficulties. (24th March 2020) Authors: Meca, N; Manzaneque, A; Castells, G; Garreta, G; Sebastián, C; Parés, I; Arcenillas, P; Nicolás, J Journal: European journal of hospital pharmacy Issue: Volume 27(2020)Supplement 1 Page Start: A135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 4CPS-234 Impact of an intensive monitoring programme on methotrexate elimination. (23rd March 2022) Authors: Sebastián, C; Castells, G; Manzaneque, A; Salazar, F; Rodrigo, M; Meca, N; Nicolás, J Journal: European journal of hospital pharmacy Issue: Volume 29(2022)Supplement 1 Page Start: A107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 5PSQ-095 Analysis of the toxicities associated with tyrosine kinase inhibitors in patients with chronic myeloid leukaemia. (24th March 2020) Authors: Garreta, G; Manzaneque, A; Velez, P; Giralt, M; Castells, G; Arcenillas, P; Meca, N; Sebastian, C; Nicolas, J Journal: European journal of hospital pharmacy Issue: Volume 27(2020)Supplement 1 Page Start: A193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗